CSR’s primary role is to handle the receipt and review of all grant applications that NIH receives. NIH separates the review process from funding decisions.
For Reviewers
Reviewers are critical to our mission to see that NIH grant applications receive, fair, independent, expert, and timely scientific reviews. We appreciate the generosity with which reviewers give their time.
Study Sections
Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.
Review Meetings
Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.
Evaluation Initiatives
Access data visualizations, reports, and analytical tools to track progress.
About CSR
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit
cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at
OPM.gov.
Dr. Lauren Penney is an anthropologist and implementation scientist. She received a Ph.D. in medical anthropology from the University of Arizona, where she also conducted post-doctoral research on the Deepwater Horizon oil spill disaster with funding from the Bureau of Ocean Energy Management and,…
Dr. Raquel Velazquez-Kronen earned her Ph.D. in epidemiology from the University at Buffalo, State University of New York. She completed a predoctoral fellowship at the National Cancer Institute, where she evaluated health risks associated with occupational radiation exposures. Prior to joining CSR…
As Branch Chief for the Scientific Review Evaluation Activities (SREA) Branch, Mr. Wheat has oversight of the organization responsible for managing the review meeting hotel contracts, non-Federal traveler contract, and reviewer reimbursement. Each and every one of these activities make review…
Dr. Paul Hewett previously served as a senior associate at the Population Council, an international non-Governmental Organization whose mission is to improve the well-being and reproductive health of current and future generations. During his more than 20 years there, he worked in developing…
How does NIH describe an Early Stage Investigator (ESI)?
What are the advantages of early stage investigator (ESI) status?
How does NIH describe an Early Stage Investigator (ESI)?
An ESI, or Early Stage Investigator, is a Program Director / Principal Investigator (PD/PI) who has completed…
Using the ECR Application and Vetting System (EAVS) you can enroll or update your information. ECRs remain in the program until they no longer meet the criteria. For example, if you have been accepted into the program but receive an R01, you will be removed from our database of ECRs even if you…
NIH Will Consider Your Career Stage IfYou submit an R01 grant applicationYou are an Early Stage Investigator (ESI)A New Investigator is someone who has not previously received substantial independent funding from NIH. Having received an award for training (such as a fellowship or K award) does not…
Dr. June Gin received a Ph.D. in resource policy and behavior from the University of Michigan's School of Environment and Sustainability, focusing on environmental sociology. Before joining CSR, she was a research health scientist at the U.S. Department of Veterans Affairs, Veterans Emergency…
Scientific and health breakthroughs are heralded in the press almost every day. You often can trace them back—directly or indirectly—to one or more NIH peer review groups that found promise in an application. To illustrate the point, we share the following stories:
Geneticist Advances…
Dr. Asifa Haider holds a Ph.D. in molecular pharmacology from New York Medical College, US, and is a licensed pharmacist from ETH-Zurich, Switzerland. She completed a postdoctoral fellowship at Rockefeller University, NY. She applied pharmacogenomics to evaluate the role of immune microenvironments…